Abstract
The comprehensive approach for the lipidomic characterization of human breast cancer and surrounding normal tissues is based on hydrophilic interaction liquid chromatography (HILIC)–electrospray ionization mass spectrometry (ESI-MS) quantitation of polar lipid classes of total lipid extracts followed by multivariate data analysis using unsupervised principal component analysis (PCA) and supervised orthogonal partial least square (OPLS). This analytical methodology is applied for the detailed lipidomic characterization of ten patients with the goal to find the statistically relevant differences between tumor and normal tissues. This strategy is selected for better visualization of differences, because the breast cancer tissue is compared with the surrounding healthy tissue of the same patient, therefore changes in the lipidome are caused predominantly by the tumor growth. A large increase of total concentrations for several lipid classes is observed, including phosphatidylinositols, phosphatidylethanolamines, phosphatidylcholines, and lysophosphatidylcholines. Concentrations of individual lipid species inside the abovementioned classes are also changed, and in some cases, these differences are statistically significant. PCA and OPLS analyses enable a clear differentiation of tumor and normal tissues based on changes of their lipidome. A notable decrease of relative abundances of ether and vinylether (plasmalogen) lipid species is detected for phosphatidylethanolamines, but no difference is apparent for phosphatidylcholines.
Similar content being viewed by others
References
Pelengaris S, Khan M (2013) Wiley: Oxford
Rosen L, Rosen G (2013) http://cancer.org/: Atlanta
Thomson CA, Thompson PA (2009) Future Oncol 5:1257–1269
Azordegan N, Fraser V, Le K, Hillyer LM, Ma DWL, Fischer G, Moghadasian MH (2013) Mol Cell Biochem 374:223–232
Pender-Cudlip MC, Krag KJ, Martini D, Yu J, Guidi A, Skinner SS, Zhang Y, Qu XY, He CW, Xu Y, Qian SY, Kang JX (2013) Cancer Sci 104:760–764
Lv WW, Yang TS (2012) Clin Biochem 45:127–133
Shannon J, King IB, Moshofsky R, Lampe JW, Gao DL, Ray RM, Thomas DB (2007) Am J Clin Nutr 85:1090–1097
Kang JX, Liu A (2013) Cancer Met Rev 32:201–210
Corsetto PA, Montorfano G, Zava S, Jovenitti IE, Cremona A, Berra B, Rizzo AM (2011) Lipids Health Dis. 10
Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, Spencer D, Berry D, Steward W, Dennison A (2009) Eur J Cancer 45:2077–2086
Doria ML, Cotrim CZ, Simoes C, Macedo B, Domingues P, Domingues MR, Helguero LA (2013) J Cell Physiol 228:457–468
Doria ML, Cotrim Z, Macedo B, Simoes C, Domingues P, Helguero L, Domingues MR (2012) Breast Cancer Res Tr 133:635–648
Hua X, Zhou ZX, Yuan L, Liu SQ (2013) Anal Chim Acta 788:135–140
Chughtai K, Jiang L, Greenwood TR, Glunde K, Heeren RMA (2013) J Lipid Res 54:333–344
Hilvo M, Denkert C, Lehtinen L, Muller B, Brockmoller S, Seppanen-Laakso T, Budczies J, Bucher E, Yetukuri L, Castillo S, Berg E, Nygren H, Sysi-Aho M, Griffin JL, Fiehn O, Loibl S, Richter-Ehrenstein C, Radke C, Hyotylainen T, Kallioniemi O, Iljin K, Oresic M (2011) Cancer Res 71:3236–3245
Smith RE, Lespi P, Di Luca M, Bustos C, Marra FA, de Alaniz MJT, Marra CA (2008) Lipids 43:79–89
Hammad LA, Wu GX, Saleh MM, Klouckova I, Dobrolecki LE, Hickey RJ, Schnaper L, Novotny MV, Mechref Y (2009) Rapid Commun Mass Spectrom 23:863–876
Kim H, Min HK, Kong G, Moon MH (2009) Anal Bioanal Chem 393:1649–1656
Holčapek M, Jirásko R, Lísa MJ (2012) Chromatogr A 1259:3–15
Han XL, Yang K, Gross RW (2012) Mass Spectrom Rev 31:134–178
Yang K, Han X (2011) Metabolites 1:21–40
Begley JKP, Redpath TW, Bolan PJ, Gilbert FJ (2012) Breast Cancer Res. 14
Glunde K, Jie C, Bhujwalla ZM (2004) Cancer Res 64:4270–4276
Klomp DWJ, van de Bank BL, Raaijmakers A, Korteweg MA, Possanzini C, Boer VO, de Berg C, van de Bosch M, Luijten PR (2011) NMR Biomed 24:1337–1342
Merchant TE, Meneses P, Gierke LW, Denotter W, Glonek T (1991) Br J Cancer 63:693–698
Kirwan GM, Johansson E, Kleemann R, Verheij ER, Wheelock AM, Goto S, Trygg J, Wheelock CE (2012) Anal Chem 84:7064–7071
Eriksson L, Byrne T, Johansson E, Trygg J, Vikström C (2013) Multi- and megavariate data analysis. Basic principles and applications. Third revised edition. MKS Umetrics AB, Malmö
Wold S, Sjostrom M, Eriksson L (2001) Chemom Intell Lab Syst 58:109–130
Trygg J, Wold S (2002) J Chemom 16:119–128
Trygg J (2002) J Chemom 16:283–293
Folch J, Lees M, Stanley GHS (1957) Biol Chem 226:497–509
Lísa M, Cífková E, Holčapek MJ (2011) Chromatogr A 1218:5146–5156
Cífková E, Holčapek M, Lísa M, Ovčačíková M, Lyčka A, Lynen F, Sandra P (2012) Anal Chem 84:10064–10070
Cífková E, Holčapek M, Lísa M (2013) Lipids 48:915–928
Holm S (1979) Scand J Stat 6:65–70
Liebisch G, Vizcaino JA, Kofeler H, Trotzmuller M, Griffiths WJ, Schmitz G, Spener F, Wakelam MJO (2013) Lipid Res 54:1523–1530
Nagan N, Zoeller RA (2001) Prog Lipid Res 40:199
Braverman NE, Moser AB (2012) Biochim Biophys Acta-Mol Basis Dis 1822:1442–1452
Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, Van Veldhoven PP, Waltregny D, Daniels VW, Machiels J, Vanderhoydonc F, Smans K, Waelkens E, Verhoeven G, Swinnen JV (2010) Cancer Res 70:8117–8126
Santos CR, Schulze A (2012) Febs J 279:2610–2623
Acknowledgments
This work was supported by ERC CZ project No. LL1302 sponsored by the Ministry of Education, Youth and Sports of the Czech Republic. E.C. acknowledges the support of the grant project no. CZ.1.07/2.3.00/30.0021 sponsored by the Ministry of Education, Youth and Sports of the Czech Republic. The help of Blanka Červená and Vitaliy Chagovets (University of Pardubice) in the extraction and data analysis and Martin Hill (Institute of Endocrinology) in the statistical evaluation is acknowledged.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in the topical collection celebrating ABCs 13th Anniversary.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 1.02 MB)
Rights and permissions
About this article
Cite this article
Cífková, E., Holčapek, M., Lísa, M. et al. Determination of lipidomic differences between human breast cancer and surrounding normal tissues using HILIC-HPLC/ESI-MS and multivariate data analysis. Anal Bioanal Chem 407, 991–1002 (2015). https://doi.org/10.1007/s00216-014-8272-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-014-8272-z